Non-Malignant T Cells as Determinants of Immunotherapeutic Response in Chronic Lymphocytic Leukemia: Towards Personalized Strategies
Oncology Research · 2026
DOI: 10.32604/or.2026.081365 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2026. Verfasst von Agata Kosmaczewska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Immunotherapy, T-Lymphocytes. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
ORCID-Profile: Agata Kosmaczewska
Zitieren
APA
Kosmaczewska, A., & Ciszak, L. (2026). Non-Malignant T Cells as Determinants of Immunotherapeutic Response in Chronic Lymphocytic Leukemia: Towards Personalized Strategies. Oncology Research. https://doi.org/10.32604/or.2026.081365
Vancouver
Kosmaczewska A, Ciszak L. Non-Malignant T Cells as Determinants of Immunotherapeutic Response in Chronic Lymphocytic Leukemia: Towards Personalized Strategies. Oncology Research. 2026. doi:10.32604/or.2026.081365
BibTeX
@article{Kosmaczewska2026,
author = {Kosmaczewska, Agata and Ciszak, Lidia},
title = {Non-Malignant T Cells as Determinants of Immunotherapeutic Response in Chronic Lymphocytic Leukemia: Towards Personalized Strategies},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2026.081365}
}
EUVIMED